NCT04586439View on ClinicalTrials.gov

A Study of JNJ-73763989 in Healthy Chinese Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Healthy
Interventions
DRUG

JNJ-73763989

JNJ-73763989 will be administered (high or low dose) as single SC injection.

Trial Locations (1)

100089

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04586439 - A Study of JNJ-73763989 in Healthy Chinese Adult Participants | Biotech Hunter | Biotech Hunter